首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Successful treatment of desmoid tumor of the chest wall with tranilast: a case report
Authors:Takahiro Goto  Tetsuo Nemoto  Koichi Ogura  Takahiro Hozumi  Nobuaki Funata
Institution:1.Department of Orthopaedic Surgery and Musculoskeletal Oncology,Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Bunkyo-ku,Japan;2.Department of Pathology,Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital,Bunkyo-ku,Japan
Abstract:

Introduction

Desmoid tumor is characterized by infiltrative growth and local recurrence often occurs after surgery. To reduce the local recurrence rate, adjuvant therapy, such as radiotherapy and pharmacotherapy with cytotoxic agents, anti-estrogen agents and non-steroidal anti-inflammatory drugs, is often applied. In addition, these non-surgical treatments are also performed in patients with unresectable desmoid tumors. We successfully treated a patient with a desmoid tumor with tranilast; an anti-allergic agent.

Case presentation

A 48-year-old Japanese man with a slow-growing desmoid tumor on his chest wall was treated with an oral administration of tranilast (300 mg per day, three times a day). Two years and two months after the commencement of his therapy, the tumor became impalpable. At this time, the oral administration of tranilast was discontinued. Two years after discontinuation of the treatment, a physical examination showed no recurrence of the tumor and he continued in a state of remission. We were successfully able to reduce the size of the tumor and thereafter maintain the reduced size.

Conclusion

Tranilast was clinically effective in our case, and is probably comparable to cytotoxic agents or anti-estrogen agents. Because tranilast has substantially fewer adverse effects than cytotoxic agents, it could be a very useful therapeutic agent for desmoid tumor.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号